Table 1.
Clinical characteristics and iron metabolism phenotype in patients and controls
Variable | ALD (N = 24) | Controls (N = 30) | P-value |
---|---|---|---|
Age (years) | 57.38 ± 1.57 | 57.40 ± 2.85 | 0.4431 |
Gender | 17M/7F | 18M/12F | 0.5673 |
Serum iron (μmol/l) | 18.03 ± 1.94 | 17.55 ± 0.67 | 0.6240 |
Serum ferritin (μg/l) | 296.22 ± 96.11 | 151.0 ± 13.83 | 0.9640 |
Transferrin saturation (%) | 32.22 ± 4.88 | 31.22 ± 0.96 | 0.4455 |
Hb (g/dl) | 12.66 ± 0.44 | 14.00 ± 0.31 | 0.0138 |
Ht (%) | 37.16 ± 1.16 | 41.48 ± 0.93 | 0.0058 |
ALT (μkat/l) | 0.62 ± 0.05 | 0.54 ± 0.05 | 0.0478 |
AST (μkat/l) | 0.81 ± 0.09 | 0.47 ± 0.03 | 0.0003 |
Data are presented as arithmetic mean ± SEM. Hb: haemoglobin; Ht: haematocrit; ALT: alanine aminotransferase; AST: aspartate aminotransferase. Normal ranges: serum iron (11–26 μmol/l), serum ferritin (male 30–250 μg/l, female 30–200 μg/l), transferrin saturation 20–45%, Hb (male 13.0–18.0 g/dl, female 11.5–16.0 g/dl), Ht (male 38–54%, female 35–47%), ALT (0.1–0.75 μkat/l) and AST (0.1–0.75 μkat/l).